Global Acute Heart Failure (AHF) Therapeutics Industry Situation and Prospects Research report

Published: Jan, 2018 | Pages: 157 | Publisher: The Stanley Consulting & Company
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Global acute heart failure (AHF) therapeutics market is expected to grow at a significant CAGR in the upcoming period as the scope and its applications are rising enormously across the globe. Acute heart failure (AHF) is also termed as acute decompensated heart failure or cardiac failure, is a syndrome that affects the heart to pump blood at a rate proportionate to the needs of the body at normal satisfying pressure. It requires immediate hospitalization or therapy.

The factors that are playing a major role in the growth of acute heart failure (AHF) therapeutics market are the growing number of patients suffering from heart failure, developing R&D sectors, the rising use of enhanced technology, and changing lifestyle. However, the high cost of therapeutics and the presence of substitute treatment may restrain overall market growth in the years to come. Acute heart failure (AHF) therapeutics market is segmented based on product type, application, and region.

Vasodilators/nitrates, B-blockers, morphine, calcium channel blockers, diuretics, cardiac glycosides, and other product types could be explored in acute heart failure (AHF) therapeuticsmarket in the forecast period.The market may be categorized based on applications like home care, hospital, clinic, and others that could be explored in the forecast period. Acute heart failure (AHF) therapeutics market is segmented geographically into Americas (North America, South America), Europe (Eastern Europe, Western Europe), Asia Pacific (India, China, Japan, New Zealand, and Australia), Middle East (UAE, Saudi, and Qatar) and Africa (South Africa).

Globally, North America may account for the substantial market share of acute heart failure (AHF) therapeutics and is estimated to lead the overall market in the years to come. The reason behind the overall market growth could be the presence of a developed healthcare infrastructure, the availability of enhanced treatments, and the growing geriatric population. The United States and Canada are the major consumers of acute heart failure (AHF) therapeutics in this region.

Europe and the Asia Pacific are also estimated to have a positive influence on future growth. Europe is the second largest region with significant market share. However, Asia Pacific is estimated to grow at the highest CAGR in the forecast period. The developing countries like India and China are the major consumers of acute heart failure (AHF) therapeutics in this region.

The key players of acute heart failure (AHF) therapeutics market are PhaseBio Pharmaceuticals, Inc., Bayer AG, Orion Corporation, Bristol-Myers Squibb Company, Novartis AG, Cardiorentis AG, Merck & Co., CVie Therapeutics Limited, and Cytokinetics, Inc.These players are concentrating on inorganic growth to sustain themselves amidst fierce competition.

Summary

The Global Acute Heart Failure (AHF) Therapeutics Industry Situation and Prospects Research report is a professional and in-depth study on the current state of the Acute Heart Failure (AHF) Therapeutics industry.

In 2016, the world economy expanded by just 2.2 per cent, the slowest rate of growth since the Great Recession of 2009. Underpinning the sluggish global economy are the feeble pace of global investment, dwindling world trade growth, flagging productivity growth and high levels of debt. World gross product is forecast to expand by 2.7 per cent in 2017 and 2.9 per cent in 2018, with this modest recovery more an indication of economic stabilization than a signal of a robust and sustained revival of global demand. Given the close linkages between demand, investment, trade and productivity, the extended episode of weak global growth may prove self-perpetuating in the absence of concerted policy efforts to revive investment and foster a recovery in productivity. This would impede progress towards the Sustainable Development Goals (SDGs), particularly the goals of eradicating extreme poverty and creating decent work for all.

For the sake of making you deeply understand the Acute Heart Failure (AHF) Therapeutics industry and meeting you needs to the report contents, Global Acute Heart Failure (AHF) Therapeutics Industry Situation and Prospects Research report will stands on the report reader's perspective to provide you a deeply analysis report with the integrity of logic and the comprehensiveness of contents. We promise that we will provide to the report reader a professional and in-depth industry analysis no matter you are the industry insider?potential entrant or investor.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Acute Heart Failure (AHF) Therapeutics market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (North America, Europe, Japan, India, China and The rest of the world), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the Acute Heart Failure (AHF) Therapeutics industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

 Table of Contents

1 Industry life cycle analysis
    1.1 Definition
    1.2 Classification of Acute Heart Failure (AHF) Therapeutics
        1.2.1 B-Blockers
        1.2.2 Calcium Channel Blockers
        1.2.3 Cardiac Glycosides
        1.2.4 Diuretics
        1.2.5 Morphine
        1.2.6 Vasodilators/Nitrates
        1.2.7 Others
    1.3 Application of Acute Heart Failure (AHF) Therapeutics
        1.3.1 Hospital
        1.3.2 Clinic
        1.3.3 Home Care
    1.4 Market size 2012-2017
    1.5 Market growth and demand growth rate
    1.6 Product technical level
    1.7 Profit margins of Acute Heart Failure (AHF) Therapeutics industry

2 Industry market structure analysis
    2.1 Supply & Consumption Analysis 2012-2017
        2.1.1 North America
        2.1.2 Europe
        2.1.3 Japan
        2.1.4 India
        2.1.5 China
        2.1.6 The rest of the world
    2.2 Competitor comparison
        2.2.1 Major Manufacture market size analysis 2012-2017
        2.2.2 Major Manufacture Revenue analysis 2012-2017
        2.2.3 Major Manufacture price?cost and gross Margin analysis 2012-2017
    2.3 Price?cost and gross Margin analysis
    2.4 Industry concentration

3 Industry market environment analysis
    3.1 Industry requirements for resources and technology
    3.2 Industry technology development trend
    3.3 The impact of national macro policy on Industry
    3.4 Other influencing factors

4 Competitive pattern analysis
    4.1 Industry competitive structure analysis by Region 2012-2017
    4.2 Industry competitive structure analysis by Manufacture 2012-2017
    4.3 Market barriers to entry analysis
    4.4 Threat of substitutes
    4.5 Acute Heart Failure (AHF) Therapeutics industry chain bargaining power analysis
    4.6 Manufacturer stress analysis
        4.6.1 Manufacturer concentration
        4.6.2 The proportion of products in the manufacturer's products
        4.6.3 Manufacturer profitability analysis

5 Major manufacturers analysis
    5.1 Bayer AG
        5.1.1 Company profile
        5.1.2 Product introduction
        5.1.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.2 Bristol-Myers Squibb Company
        5.2.1 Company profile
        5.2.2 Product introduction
        5.2.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.3 Cardiorentis AG
        5.3.1 Company profile
        5.3.2 Product introduction
        5.3.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.4 CVie Therapeutics Limited
        5.4.1 Company profile
        5.4.2 Product introduction
        5.4.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.5 Cytokinetics, Inc.
        5.5.1 Company profile
        5.5.2 Product introduction
        5.5.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.6 Merck & Co.
        5.6.1 Company profile
        5.6.2 Product introduction
        5.6.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.7 Novartis AG
        5.7.1 Company profile
        5.7.2 Product introduction
        5.7.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.8 Orion Corporation
        5.8.1 Company profile
        5.8.2 Product introduction
        5.8.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    5.9 PhaseBio Pharmaceuticals, Inc
        5.9.1 Company profile
        5.9.2 Product introduction
        5.9.3 Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017

6 Product differentiation analysis
    6.1 Consumption survey analysis 2012-2017
    6.2 Investigation and analysis of consumer groups
        6.2.1 Consumer group structure
        6.2.2 Characteristics of different consumer groups
        6.2.3 Downstream consumer market demand
    6.3 Consumption regional market survey
    6.4 Brand satisfaction survey
        6.4.1 Brand structure
        6.4.2 Brand regional differences analysis
        6.4.3 Brand satisfaction analysis

7 Channel analysis (marketing model and import & Export)
    7.1 Sales channel analysis
    7.2 Composition of consumption place
    7.3 Import & Export market analysis 2012-2017
        7.3.1 Import & Export market structure
        7.3.2 Regional pattern of import & Export market
        7.3.3 Consumption value and Growth rate statistics

8 Industry chain and manufacturing cost analysis
    8.1 Upstream Major Raw Materials Suppliers Analysis of Acute Heart Failure (AHF) Therapeutics
        8.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Acute Heart Failure (AHF) Therapeutics
        8.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Acute Heart Failure (AHF) Therapeutics by Regions
    8.2 Upstream Major Equipment Suppliers Analysis of Acute Heart Failure (AHF) Therapeutics
        8.2.1 Major Equipment Suppliers with Contact Information Analysis of Acute Heart Failure (AHF) Therapeutics
        8.2.2 Major Equipment Suppliers with Product Pictures Analysis of Acute Heart Failure (AHF) Therapeutics by Regions
    8.3 Downstream Major Consumers Analysis of Acute Heart Failure (AHF) Therapeutics
        8.3.1 Major Consumers with Contact Information Analysis of Acute Heart Failure (AHF) Therapeutics
        8.3.2 Major Consumers with Consumption Volume Analysis of Acute Heart Failure (AHF) Therapeutics by Regions
    8.4 Supply Chain Relationship Analysis of Acute Heart Failure (AHF) Therapeutics
    8.5 Raw Material Suppliers and Price Analysis of Acute Heart Failure (AHF) Therapeutics
    8.6 Labor Cost Analysis of Acute Heart Failure (AHF) Therapeutics
    8.7 Manufacturing Cost Structure Analysis of Acute Heart Failure (AHF) Therapeutics
    8.8 Other Costs Analysis of Acute Heart Failure (AHF) Therapeutics
    8.9 Manufacturing Cost Structure Analysis of Acute Heart Failure (AHF) Therapeutics
    8.10 Manufacturing Process Analysis of Acute Heart Failure (AHF) Therapeutics

9 Industry development trend analysis
    9.1 Supply & Consumption Analysis 2017-2021
        9.1.1 North America
        9.1.2 Europe
        9.1.3 Japan
        9.1.4 India
        9.1.5 China
        9.1.6 The rest of the world

10 Strategic analysis

11 Conclusion

12 Appendix
    Author List
    Disclosure Section
    Research Methodology
    Data Source
    China Disclaimer

List of Tables

    Table Type of Acute Heart Failure (AHF) Therapeutics
    Table Applications of Acute Heart Failure (AHF) Therapeutics
    Table Major Consumers of Hospital
    Table Major Consumers of Clinic
    Table Major Consumers of Home Care
    Table Global Acute Heart Failure (AHF) Therapeutics Industry gross Margin level by Region 2012-2017
    Table Global Supply Mark size of Acute Heart Failure (AHF) Therapeutics in 2012-2017
    Table Global Consumption Mark size of Acute Heart Failure (AHF) Therapeutics in 2012-2017
    Table North America Supply market analysis 2012-2017
    Table North America Consumption market analysis 2012-2017
    Table Europe Supply market analysis 2012-2017
    Table Europe Consumption market analysis 2012-2017
    Table Japan Supply market analysis 2012-2017
    Table Japan Consumption market analysis 2012-2017
    Table India Supply market analysis 2012-2017
    Table India Consumption market analysis 2012-2017
    Table China Supply market analysis 2012-2017
    Table China Consumption market analysis 2012-2017
    Table The rest of the world Supply market analysis 2012-2017
    Table The rest of the world Consumption market analysis 2012-2017
    Table Major Manufacture Capacity market size analysis 2012-2017
    Table Major Manufacture Production market size analysis 2012-2017
    Table Major Manufacture Revenue market size analysis 2012-2017
    Table Major Manufacture price Competitive analysis 2012-2017
    Table Major Manufacture cost Competitive analysis 2012-2017
    Table Major Manufacture gross Margin Competitive analysis 2012-2017
    Table Price Comparison of Acute Heart Failure (AHF) Therapeutics by Regions 2012-2017 (USD/Unit)
    Table Price of Different Acute Heart Failure (AHF) Therapeutics Product Types (USD/Unit)
    Table Market barriers to entry analysis?Top 5?
    Table Competitive analysis of substitutes
    Table Acute Heart Failure (AHF) Therapeutics Industry chain bargaining power analysis
    Table the proportion of products in the manufacturer's products
    Table Major Manufacture Revenue comparative analysis 2012-2017
    Table Major Manufacture Gross Margin comparative analysis 2012-2017
    Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bayer AG Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table Cardiorentis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table CVie Therapeutics Limited Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table Cytokinetics, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table Merck & Co. Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Merck & Co. Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Novartis AG Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table Orion Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table Orion Corporation Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table PhaseBio Pharmaceuticals, Inc Basic Information, Manufacturing Base, Sales Area and Its Competitors
    Table PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Capacity, Production, price, revenue, cost and gross Margin analysis 2012-2017
    Table marketing model analysis
    Table Acute Heart Failure (AHF) Therapeutics Consumption volume market share analysis by region 2012-2017
    Table Regional Acute Heart Failure (AHF) Therapeutics Import & Export comparative analysis 2012-2017
    Table North America Acute Heart Failure (AHF) Therapeutics Production, Consumption, Import & Export (2012-2017)
    Table Europe Acute Heart Failure (AHF) Therapeutics Production, Consumption, Import & Export (2012-2017)
    Table Japan Acute Heart Failure (AHF) Therapeutics Production, Consumption, Import & Export (2012-2017)
    Table India Acute Heart Failure (AHF) Therapeutics Production, Consumption, Import & Export (2012-2017)
    Table China Acute Heart Failure (AHF) Therapeutics Production, Consumption, Import & Export (2012-2017)
    Table The rest of the world Acute Heart Failure (AHF) Therapeutics Production, Consumption, Import & Export (2012-2017)
    Table Major Raw Materials Suppliers with Contact Information of Acute Heart Failure (AHF) Therapeutics
    Table Major Raw Materials Suppliers with Supply Volume of Acute Heart Failure (AHF) Therapeutics by Regions
    Table Major Equipment Suppliers with Contact Information of Acute Heart Failure (AHF) Therapeutics
    Table Major Equipment Suppliers with Product Pictures of Acute Heart Failure (AHF) Therapeutics by Regions
    Table Major Consumers with Contact Information of Acute Heart Failure (AHF) Therapeutics
    Table Major Consumers with Consumption Volume of Acute Heart Failure (AHF) Therapeutics by Regions
    Table Major Raw Materials Analysis of Acute Heart Failure (AHF) Therapeutics
    Table Annual Depreciation Rate of Equipment in 2012-2017
    Table Manufacturing Cost Structure Analysis of Acute Heart Failure (AHF) Therapeutics in 2015
    Table World Acute Heart Failure (AHF) Therapeutics Industry market Forecast analysis 2017-2021
    Table Region Consumption market share of Acute Heart Failure (AHF) Therapeutics 2017-2021
    Table North America Supply market analysis 2017-2021
    Table North America Consumption market analysis 2017-2021
    Table Europe Supply market analysis 2017-2021
    Table Europe Consumption market analysis 2017-2021
    Table Japan Supply market analysis 2017-2021
    Table Japan Consumption market analysis 2017-2021
    Table India Supply market analysis 2017-2021
    Table India Consumption market analysis 2017-2021
    Table China Supply market analysis 2017-2021
    Table China Consumption market analysis 2017-2021
    Table The rest of the world Supply market analysis 2017-2021
    Table The rest of the world Consumption market analysis 2017-2021
    Table New Project SWOT Analysis of Acute Heart Failure (AHF) Therapeutics